Travelers in the UK are in for a surprise: most countries in Europe offer better healthcare than the United States.

    According to the latest data from the U.K. Office for National Statistics (ONS), health care costs in the U and UK are nearly the same, but some countries in the world are better equipped to treat people with chronic illnesses, including HIV/AIDS and TB.

    The country with the highest average annual cost per capita is Russia, with an average of $23,637.

    The United States, on the other hand, has the second highest average, at $32,967.

    The average cost of care for a person with chronic illness is about $7,400.

    However, many other countries offer much lower rates, ranging from less than $1,000 to over $20,000.

    Here’s a look at some of the most affordable places in the Western world for healthcare.

    The US: While the US has a reputation as a place for health care in need, it is actually the world’s second-best health care system, behind only Japan, according to the WHO.

    In 2017, the United Kingdom topped the WHO rankings, with the average cost per person of care being $26,811.

    The UK has been praised for being a world leader in HIV/Aids prevention and treatment, and for its long-standing HIV/ Aids policy.

    But it is also a leader in high-cost healthcare.

    According, the average US health care bill is $25,814, while the average UK bill is only $13,836.

    Canada: Canada offers better health care than the U, and the cost per patient is lower than the UK at $22,921.

    Canada also offers better quality of care, which can lead to fewer costly medical procedures and longer life spans.

    According the OECD, the cost of health care services in Canada is about 20% lower than in the United Stated.

    It also offers lower overall costs, and has higher access to health care resources such as prescription drugs and health insurance.

    However it does have some of its health care systems underdeveloped, and many Canadians rely on public health for their health care needs.

    Germany: Germany has been a leader on combating the spread of HIV/ AIDS, but the average annual bill for healthcare in Germany is more than $50,000, according the UES.

    The healthcare system has seen a decline in funding since 2009.

    As a result, the country’s health care spending is currently the third highest in the EU, behind the Netherlands and the United Arab Emirates.

    The U.S. and Germany have a lot of similarities, but they also have some differences.

    In the U-S, healthcare costs are higher than in any other country, including in the NHS.

    According TOI, the U of S is the most expensive country in the OECD.

    For some Americans, it could be due to the fact that many states require insurers to cover their premiums.

    For other Americans, the higher cost of healthcare is due to other factors, including a higher percentage of the population being uninsured and a greater percentage of adults who are underinsured.

    It is also not unusual for healthcare costs to go up for people with pre-existing conditions, which are higher in the US.

    China: China offers many benefits, including access to many more affordable medicines and better healthcare.

    But, China has one major drawback: the cost is almost the same as the U S. and Japan.

    As of 2018, the US spends more than 4% of its gross domestic product (GDP) on healthcare, whereas the average per capita cost of life-sustaining medical treatment is only about 1% in China.

    China’s healthcare system is not as developed as the rest of the world.

    In 2018, a report by the WHO said that the U was not yet fully integrated into the global healthcare system.

    However the WHO is working on improving the situation.

    In 2020, the World Health Organization announced the creation of the China Collaborative on Health, a group that will work on integrating China’s health systems into the healthcare system in 2020.

    It will also be able to develop and launch new health and medical services, including new medicines.